NEWS ROOM

See the latest news from our company below or use the search feature. For more information, contact our head office or the Marketing Communications Manager directly at marcom@arazygroup.com.


 

CFDA PROPOSES TO EXEMPT MORE MEDICAL DEVICES FROM CLINICAL TRIALS

by Arazy Group | May 26, 2017
The China Food and Drug Administration (CFDA) is proposing the exemption of a further 28 types of medical device from clinical trials.

The list of products in the draft plan is made up of 22 types of Class II medical device and six Class III medical devices.  

Comments on the proposal can be submitted until June 20, 2017. 

Contact us today for more information on the proposed changes and to discover how regulatory intelligence and registration management system LICENSALE.COM® assists MedTech firms in gaining access to 100+ markets faster and more cost-effectively than ever before.


 
 
 
 

 

Back to Press Room

latest news
  • Feb 21 2018
    REGULATORY UPDATE - TECRES MEDICAL

    Saudi Arabia: Tecres Medical's Rally Bone Cements were approved for sale with LICENSALE.COM®. ...

    Read More
  • Feb 19 2018
    REGULATORY UPDATE - LUMINEX

    Brazil: Luminex's xTAG Cystic Fibrosis 71 Kit v2 was approved for sale with LICENSALE.COM®. ...

    Read More
  • Feb 1 2018
    REGULATORY UPDATE - LEXMARK

    UAE: Lexmark's Media Writer, PACS Scan and EHR Gateway were approved for sale with LICENSALE.COM®. ...

    Read More
  • Jan 30 2018
    REGULATORY UPDATE - SYNTHETIC MR

    USA: Synthetic MR's SyMRI Neuro was approved for sale with LICENSALE.COM®. ...

    Read More
  • Jan 9 2018
    REGULATORY UPDATE - NOVASIGHT

    EU: Novasight's Eyeswift was approved for sale with LICENSALE.COM®. ...

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP